Search

everythinglearnresearchcommunity

for

Search:↓

Keratin-based hydrogels with calcium are effective for delivering anti-fibrotic drugs.

TAK-279 effectively reduces psoriasis symptoms and is safe.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Five different TPO gene mutations were found in PCOS patients with thyroid hormone issues.

The vitamin D receptor helps maintain hair and bone health even without binding vitamin D.

Drug repurposing can be cost-effective but needs more testing for safety and effectiveness.

Orlistat might block the body's ability to absorb thyroid medication.

Serenoa repens extract shows promise as a natural treatment for prostate cancer.

New male contraceptive pills show promise in reducing sperm production with mild side effects.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Estrogen deficiency can reduce the enzyme activity needed to activate vitamin D.

HST and HST/F promote hair growth and may help treat alopecia.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Potassium channel openers like minoxidil boost hair growth.

Prescription and alternative therapies for hair loss will be compared for effectiveness.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Topical prostaglandin analogs may help with hair growth but more research is needed.

The compounds tested could potentially treat hair loss and alopecia.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Continued research and awareness are needed to improve treatments for androgen-dependent diseases.

PP405 may help hair growth by activating hair follicle stem cells.

Including androgens in hormone therapy may lower breast cancer risk.

A woman's cyclic Cushing syndrome was caused by a tumor in her adrenal gland that produced ACTH.